Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fanconi Anemia | 3 | 2017 | 44 | 1.250 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 4 | 2020 | 15 | 1.040 |
Why?
|
| DNA Damage | 4 | 2020 | 513 | 0.810 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 3 | 2018 | 9 | 0.770 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2012 | 96 | 0.740 |
Why?
|
| Fanconi Anemia Complementation Group C Protein | 1 | 2018 | 3 | 0.610 |
Why?
|
| DNA Repair | 2 | 2017 | 585 | 0.550 |
Why?
|
| Chondrogenesis | 2 | 2013 | 26 | 0.510 |
Why?
|
| Osteoclasts | 2 | 2013 | 55 | 0.500 |
Why?
|
| Signal Transduction | 6 | 2018 | 4534 | 0.470 |
Why?
|
| Flavonoids | 2 | 2012 | 78 | 0.460 |
Why?
|
| Metabolomics | 1 | 2018 | 423 | 0.460 |
Why?
|
| MAP Kinase Signaling System | 2 | 2013 | 314 | 0.450 |
Why?
|
| NFATC Transcription Factors | 2 | 2013 | 44 | 0.440 |
Why?
|
| Bone Resorption | 2 | 2013 | 42 | 0.440 |
Why?
|
| Kaempferols | 1 | 2013 | 5 | 0.430 |
Why?
|
| RANK Ligand | 2 | 2013 | 52 | 0.430 |
Why?
|
| NF-kappa B | 2 | 2013 | 459 | 0.430 |
Why?
|
| Flavones | 1 | 2013 | 10 | 0.430 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2013 | 85 | 0.420 |
Why?
|
| Neovascularization, Pathologic | 2 | 2012 | 240 | 0.410 |
Why?
|
| Down-Regulation | 2 | 2012 | 698 | 0.380 |
Why?
|
| Benzylamines | 1 | 2011 | 15 | 0.360 |
Why?
|
| Benzopyrans | 1 | 2011 | 20 | 0.360 |
Why?
|
| Enzyme Activators | 1 | 2011 | 10 | 0.360 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2011 | 36 | 0.360 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 206 | 0.340 |
Why?
|
| Neoplasms | 3 | 2018 | 2794 | 0.310 |
Why?
|
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2008 | 5 | 0.300 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2008 | 20 | 0.300 |
Why?
|
| Androstadienes | 1 | 2008 | 49 | 0.300 |
Why?
|
| Osteosarcoma | 1 | 2011 | 255 | 0.290 |
Why?
|
| Gene Expression Regulation | 6 | 2018 | 2522 | 0.270 |
Why?
|
| Politics | 1 | 2007 | 59 | 0.270 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2008 | 293 | 0.250 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 1694 | 0.200 |
Why?
|
| Global Health | 1 | 2007 | 564 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 1893 | 0.200 |
Why?
|
| Cell Line | 4 | 2013 | 2758 | 0.180 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 3348 | 0.170 |
Why?
|
| Genomic Instability | 1 | 2020 | 229 | 0.160 |
Why?
|
| Polyadenylation | 1 | 2018 | 55 | 0.150 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 141 | 0.140 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2017 | 20 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2020 | 618 | 0.140 |
Why?
|
| Cloning, Molecular | 1 | 2018 | 897 | 0.130 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 282 | 0.130 |
Why?
|
| Cartilage | 2 | 2013 | 48 | 0.130 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 2512 | 0.130 |
Why?
|
| Proteoglycans | 2 | 2013 | 88 | 0.130 |
Why?
|
| Cell Differentiation | 3 | 2013 | 1896 | 0.130 |
Why?
|
| Alkaline Phosphatase | 2 | 2013 | 98 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2013 | 62 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 358 | 0.120 |
Why?
|
| Proteins | 1 | 2020 | 1036 | 0.120 |
Why?
|
| Animals | 6 | 2018 | 34219 | 0.110 |
Why?
|
| Lipids | 1 | 2018 | 522 | 0.110 |
Why?
|
| Humans | 14 | 2020 | 125167 | 0.110 |
Why?
|
| Mice | 5 | 2013 | 17632 | 0.110 |
Why?
|
| Nepal | 2 | 2018 | 10 | 0.110 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2013 | 9 | 0.110 |
Why?
|
| Collagen Type II | 1 | 2013 | 24 | 0.110 |
Why?
|
| SOX9 Transcription Factor | 1 | 2013 | 80 | 0.100 |
Why?
|
| KB Cells | 1 | 2012 | 5 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2011 | 628 | 0.100 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2012 | 26 | 0.100 |
Why?
|
| Mitochondria | 1 | 2017 | 680 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2017 | 766 | 0.100 |
Why?
|
| Microvessels | 1 | 2012 | 57 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2018 | 1007 | 0.100 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 295 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2012 | 230 | 0.090 |
Why?
|
| Biomarkers | 2 | 2018 | 3090 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2011 | 22 | 0.090 |
Why?
|
| Diterpenes | 1 | 2011 | 28 | 0.090 |
Why?
|
| Glycosides | 1 | 2010 | 7 | 0.090 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2010 | 37 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2012 | 889 | 0.080 |
Why?
|
| Cell Movement | 1 | 2012 | 847 | 0.080 |
Why?
|
| Fluticasone | 1 | 2008 | 15 | 0.080 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2020 | 140 | 0.080 |
Why?
|
| Female | 6 | 2018 | 66783 | 0.070 |
Why?
|
| Defecation | 1 | 2008 | 30 | 0.070 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2008 | 18 | 0.070 |
Why?
|
| Administration, Inhalation | 1 | 2008 | 180 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3157 | 0.070 |
Why?
|
| Glucose | 1 | 2012 | 877 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2020 | 735 | 0.070 |
Why?
|
| Stem Cells | 1 | 2011 | 707 | 0.060 |
Why?
|
| Models, Genetic | 2 | 2018 | 760 | 0.060 |
Why?
|
| Protein Binding | 2 | 2020 | 1757 | 0.060 |
Why?
|
| Time Factors | 2 | 2020 | 6334 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2007 | 871 | 0.060 |
Why?
|
| Asthma | 1 | 2008 | 756 | 0.040 |
Why?
|
| Protein Stability | 1 | 2020 | 161 | 0.040 |
Why?
|
| Mutation | 3 | 2018 | 5842 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 203 | 0.040 |
Why?
|
| Chromosomal Instability | 1 | 2018 | 57 | 0.040 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2017 | 15 | 0.040 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2017 | 15 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2017 | 144 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2018 | 238 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2017 | 110 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2017 | 357 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2018 | 358 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2017 | 149 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2018 | 333 | 0.030 |
Why?
|
| Triglycerides | 1 | 2018 | 575 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 662 | 0.030 |
Why?
|
| Life Style | 1 | 2018 | 416 | 0.030 |
Why?
|
| Cholesterol | 1 | 2018 | 541 | 0.030 |
Why?
|
| Histones | 1 | 2018 | 524 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 1304 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 571 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 1398 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 2715 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 1561 | 0.020 |
Why?
|
| Male | 4 | 2018 | 61503 | 0.020 |
Why?
|
| Growth Plate | 1 | 2011 | 20 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2018 | 3300 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 90 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2011 | 104 | 0.020 |
Why?
|
| Bone Diseases | 1 | 2011 | 44 | 0.020 |
Why?
|
| Tibia | 1 | 2011 | 70 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 145 | 0.020 |
Why?
|
| Risk Factors | 2 | 2018 | 10309 | 0.020 |
Why?
|
| Adult | 1 | 2008 | 29634 | 0.020 |
Why?
|
| Pressure | 1 | 2008 | 131 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2008 | 172 | 0.020 |
Why?
|
| Syndrome | 1 | 2008 | 1120 | 0.010 |
Why?
|
| Acute Coronary Syndrome | 1 | 2008 | 216 | 0.010 |
Why?
|
| Middle Aged | 2 | 2018 | 26932 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 19871 | 0.010 |
Why?
|
| Heart Failure | 1 | 2008 | 2297 | 0.010 |
Why?
|